Restoring Bcl-xL levels benefits a mouse model of spinal muscular atrophy
Currently, no curative treatment is available for spinal muscular atrophy (SMA). Since the degeneration of spinal motor neurons in SMA is mediated by apoptosis, over-expression of an anti-apoptotic factor, Bcl-xL, may benefit SMA. Here, we crossed a mouse model of SMA with Bcl-xL transgenic mice to...
Main Authors: | Li-Kai Tsai, Ming-Shiun Tsai, Chen-Hung Ting, Sue-Hong Wang, Hung Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-09-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996108001046 |
Similar Items
-
A new model to study spinal muscular atrophy: Neurite degeneration and cell death is counteracted by BCL-XL Overexpression in motoneurons
by: Ana Garcera, et al.
Published: (2011-06-01) -
Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer
by: Yumin Wei, et al.
Published: (2023-06-01) -
Involvement of Bcl-xL in Neuronal Function and Development
by: Julie Bas, et al.
Published: (2021-03-01) -
Regulation of Platelet Production and Life Span: Role of Bcl-xL and Potential Implications for Human Platelet Diseases
by: Emma C. Josefsson, et al.
Published: (2020-10-01) -
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
by: Mike-Andrew Westhoff, et al.
Published: (2022-01-01)